• 5-AMP-Activated Protein Kinase, Gamma-2 Subunit (PRKAG2) Mutation Analysis
  • Thalassemia and Hemoglobinopathy Evaluation
  • Apolipoprotein A-I (APOA1) Gene Analysis
  • Bartonella, Molecular Detection, PCR
  • Polyoma BK Virus, PCR, Plasma
  • Methylmalonic Acid (MMA), Quantitative, Serum
  • Alprazolam, SerumĀ 
  • Usher Syndrome, Types 1F and 3 (PCDH15 and CLRN1), 2 Variants
  • Hepatitis B Virus (HBV) by Molecular Method, Qualitative
  • Chronic conjunctivitis
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /CEBPA (CCAAT enhancer binding protein alpha) Gene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

CEBPA (CCAAT enhancer binding protein alpha) Gene Mutation Analysis
Medical Test

ICD10
Access to CEBPA (CCAAT enhancer binding protein alpha) Gene Mutation Analysis is restricted.